Close Menu

Over at Adaptive Complexity, Michael White blogs about what many perceive as a major goal of synthetic biology: that is, establishing a set of standard biochemical parts that can be used to build systems. "I'm skeptical that any single standardized biological device will hold up well under very different cellular contexts, without a lot of trial-and error modifications," he writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.